Your Article Summary
See Latest ArticlesCosts of second-generation antihistamines in the treatment of allergic rhinitis: US perspective
Current Medical Research and Opinion, 06/26/09
Hay JW et al. - Preliminary evidence suggests that newer SGAs offer clinical, pharmacodynamic, and pharmacokinetic advantages that may translate into superior cost-effectiveness in the treatment of AR. Further study is warranted to clarify the pharmacoeconomic impact of the newer SGAs and to establish their relative cost-effectiveness.
Joel W. Hay, 07/13/09
| The direct costs associated with allergic rhinitis (AR) exceeded $11 billion in 2005, with nearly 60% of the total expenditure spent on prescription medications. The majority of individuals with AR in the U.S. are treated with antihistamines; approximately two thirds of those use first-generation antihistamines (FGAs) and one third uses second-generation antihistamines (SGAs). Although less expensive per unit use, FGAs may actually result in increased overall medical expenditures compared with SGAs owing to lost productivity and increased emergency department visits related to adverse events. Our recent literature review demonstrates that SGAs offer clinical, pharmacodynamic, and pharmacokinetic advantages that may translate into greater cost-effectiveness in the treatment of AR. Further study is warranted to clarify the pharmacoeconomic impact of SGAs and to establish their relative cost-effectiveness over FGAs. Current managed care policies that restrict the use of prescription vs. over-the-counter SGAs should be reexamined for cost-effectiveness. |
Today in Allergy...keeping you current
Receive free subspecialty "5-minute updates" via email
Montelukast in the treatment of asthma and beyond
Expert Review of Clinical Immunology, 11/23/09
Dissolution in nasal fluid, retention and anti-inflammatory activity of fluticasone furoate in human nasal tissue ex vivo
Clinical and Experimental Allergy, 11/20/09
Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysine-aspirin nasal challenge in vivo model
Allergy, 11/17/09
Today in Nose...keeping you current
Receive free subspecialty "5-minute updates" via email
Automated software for analysis of ciliary beat frequency and metachronal wave orientation in primary ciliary dyskinesia
European Archives of Oto-Rhino-Laryngology, 11/25/09
Extranasopharyngeal angiofibroma of the nasal septum: A case report
ENT Journal, 11/25/09
Azelastine nasal spray for the treatment of allergic and nonallergic rhinitis
Expert Review of Clinical Immunology, 11/23/09